Tirzepatide

Product Overview

Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has gained significant attention in scientific and clinical research for its interactions with metabolic signalling pathways, glucose regulation and energy balance.

Its dual-receptor activity makes Tirzepatide a compound of interest in studies investigating metabolic function, insulin signalling and appetite-regulating mechanisms.

Manufacturing

Tirzepatide is manufactured using specialised peptide synthesis and purification techniques designed to achieve precise molecular structure, purity and consistency.

Each batch undergoes independent third-party testing to assess peptide identity and purity, with laboratory results. 

The peptide is carefully handled and packaged to help maintain product integrity throughout storage and transport.

Research Applications

Tirzepatide is extensively studied in scientific research exploring:

• Metabolic Regulation: Investigation of biological pathways involved in energy balance and metabolic homeostasis.

• Glucose Metabolism: Examination of GIP and GLP-1 receptor activity and their roles in glucose-dependent insulin secretion.

• Insulin Signalling: Research into pancreatic beta-cell responses and insulin-related regulatory mechanisms.

• Appetite Regulation: Investigation of hormonal signalling pathways associated with hunger, satiety and food intake.

• Lipid Metabolism: Studies examining the relationship between incretin receptor signalling, adipose tissue and metabolic function.

Disclaimer

For research purposes only. Not for human consumption.